Vlad Tudor Motoc, MD | |
205 N East Ave, Jackson, MI 49201-1753 | |
(517) 788-4800 | |
Not Available |
Full Name | Vlad Tudor Motoc |
---|---|
Gender | Male |
Speciality | Geriatric Medicine |
Experience | 31 Years |
Location | 205 N East Ave, Jackson, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164462693 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 4301085310 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Heartland Home Health Care And Hospice | Mason, MI | Hospice |
Mclaren Northern Michigan | Petoskey, MI | Hospital |
Edward W Sparrow Hospital | Lansing, MI | Hospital |
Faith Haven Senior Care Centre | Jackson, MI | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mclaren Northern Michigan | 9931018181 | 59 |
Sound Physicians Of Florida Iv, Llc | 6002198082 | 29 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Spectrum Health Primary Care Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | W.a. Foote Memorial Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | W.a. Foote Memorial Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831123728 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000875 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Carelink Of Jackson A Community Owned Specialty Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053781625 PECOS PAC ID: 3678484482 Enrollment ID: O20040114000467 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Mclaren Northern Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760736094 PECOS PAC ID: 9931018181 Enrollment ID: O20040415001193 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Pulmonary Clinics Of Southern Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992818207 PECOS PAC ID: 4284681784 Enrollment ID: O20050406001085 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Hospitalist Medicine Physicians Of Michigan Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013180181 PECOS PAC ID: 4486703170 Enrollment ID: O20090529000290 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Sound Inpatient Physicians-michigan Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639311996 PECOS PAC ID: 5395896849 Enrollment ID: O20090624000252 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Michigan Continuum Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861800666 PECOS PAC ID: 2264652213 Enrollment ID: O20140925002030 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Entity Name | Hospitalist Medicine Physicians Of Michigan - Kalamazoo, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669017380 PECOS PAC ID: 3577991496 Enrollment ID: O20200306002096 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Vlad Tudor Motoc, MD Department 272801, Po Box 67000, Detroit, MI 48267-2728 Ph: (517) 841-6913 | Vlad Tudor Motoc, MD 205 N East Ave, Jackson, MI 49201-1753 Ph: (517) 788-4800 |
News Archive
The often forgotten lymphatic circulatory system may be intimately involved in vascular disorders, according to a study by researchers from The University of Texas Health Science Center at Houston (UTHealth) and University of Michigan. Their research was reported recently in the Proceedings of the National Academy of Sciences.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances.
A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Livingston-based Touch Bionics, the developer and manufacturer of world-leading upper limb prosthetic technologies, has been sold by its shareholders – including Archangel Investors, Scottish Investment Bank and management – to Össur Hf, the Iceland-based provider of prosthetic, bracing and supports solutions, for a consideration of £27.5 million on a cash and debt free basis.
› Verified 2 days ago
James Brown Chauncey Iii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-788-4800 | |
Mrs. Bharti Sachdev, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 766 W Michigan Ave, Jackson, MI 49201 Phone: 517-784-9910 Fax: 517-787-4404 | |
Dr. Gregory A Naylor, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 Fax: 517-780-9286 | |
Rolando Manalo Beredo, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 426 N Jackson St, Jackson, MI 49201 Phone: 517-788-6336 Fax: 517-788-9035 | |
Essam Y. Tellawi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-4800 | |
Dr. Fadi Alali, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 744 W Michigan Ave Ste 201, Jackson, MI 49201 Phone: 517-205-7618 Fax: 517-205-7639 | |
Dr. Abdulbaset M. Salim, MD, MPH Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-1328 |